Primary peritoneal carcinoma (PPC) arises from the abdominal lining and behaves much like epithelial ovarian cancer. Diagnosis uses imaging, CA-125, and biopsy. Standard care remains cytoreductive surgery plus platinum-based chemotherapy; PARP inhibitors are now commonly used as maintenance in eligible patients. Long-term surveillance and genetic testing are important.
Primary peritoneal carcinoma is a rare, ovarian-type cancer of the abdominal lining. It causes vague symptoms such as bloating and abdominal pain and is treated like advanced ovarian cancer with surgery, platinum-based chemotherapy, and, when appropriate, targeted therapies including PARP inhibitors.
Ovarian cancer often causes vague gastrointestinal or pelvic symptoms that can be mistaken for benign conditions. Persistent bloating, pelvic pain, early satiety, and urinary changes warrant medical evaluation - especially for women with a family history or genetic risk.